PRESS RELEASE published on 04/09/2025 at 07:00, 1 year 1 month ago Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2 Valneva and LimmaTech announce first vaccination in Phase 2 infant study of tetravalent Shigella vaccine candidate S4V2. Study aims to combat shigellosis, a deadly diarrheal disease Valneva Phase 2 Study Shigella Vaccine Shigellosis LimmaTech
PRESS RELEASE published on 04/09/2025 at 06:59, 1 year 1 month ago Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity Biophytis confirms the launch of the Phase 2 OBA Clinical Trial in Obesity in 2025. The study aims to evaluate the efficacy of BIO101 in reducing muscle strength loss caused by GLP-1 agonists in obese patients Biophytis BIO101 Obesity Muscle Strength Phase 2 OBA Clinical Trial
PRESS RELEASE published on 04/09/2025 at 06:40, 1 year 1 month ago Bondholder meetings approve amendments proposed by MBT Systems GmbH and Meyer Burger Technology AG Bondholder meetings approve proposed amendments by MBT Systems GmbH and Meyer Burger Technology AG for 2027 and 2029 convertible bonds, exceeding required threshold Convertible Bonds Amendments Meyer Burger Technology AG Bondholder Meetings MBT Systems GmbH
PRESS RELEASE published on 04/09/2025 at 06:30, 1 year 1 month ago First trading day of Cham Swiss Properties Cham Swiss Properties AG debuts on SIX Swiss Exchange after successful merger, now one of Switzerland's top real estate companies with CHF 1.6 billion portfolio. Targets sustainable growth and dividend distribution Merger Real Estate Portfolio Growth SIX Swiss Exchange Cham Swiss Properties AG
PRESS RELEASE published on 04/09/2025 at 04:00, 1 year 1 month ago QNX Now Powering WeRide's Next-Generation ADAS Platform QNX and WeRide collaborate to accelerate Software Defined Vehicles deployment for automotive industry with advanced ADAS technology integrated into Chery's EXEED Sterra ES and ET models in China QNX Chery Software Defined Vehicles WeRide ADAS Technology
PRESS RELEASE published on 04/08/2025 at 23:45, 1 year 1 month ago Redcare successfully executes placement of new convertible bonds and buys back part of the outstanding convertible bonds. Redcare Pharmacy N.V. successfully executes placement of new convertible bonds amounting to EUR 300 million with a maturity of seven years and buys back a part of outstanding convertible bonds, strengthening its balance sheet and capital structure Convertible Bonds Debt Financing Capital Structure Redcare Pharmacy N.V. E-Pharmacy
PRESS RELEASE published on 04/08/2025 at 23:21, 1 year 1 month ago EQS-Adhoc: Redcare Pharmacy N.V. successfully places EUR 300 million convertible bonds and repurchases part of its outstanding EUR 225 million 0.00% convertible bonds due 2028 Redcare Pharmacy N.V. successfully places EUR 300 million convertible bonds and repurchases part of its outstanding EUR 225 million 0.00% convertible bonds due 2028. The company intends to use the net proceeds for general corporate purposes Convertible Bonds Repurchase Redcare Pharmacy N.V. EUR 300 Million Financial Financing
PRESS RELEASE published on 04/08/2025 at 22:58, 1 year 1 month ago EQS-Adhoc: Semperit AG Holding: US tariff policy and lower global order activity lead to adjustment of EBITDA guidance for 2025 – Guidance 2026 suspended due to current high uncertainties Semperit AG Holding adjusts EBITDA guidance for 2025 due to US tariffs and lower global order activity. Guidance for 2026 suspended EBITDA Guidance Semperit AG Holding 2025 US Tariffs Global Order Activity
PRESS RELEASE published on 04/08/2025 at 22:47, 1 year 1 month ago MicroVision Announces Retail Investor Day in Redmond, WA on May 20, 2025 MicroVision, Inc. to host MicroVision Retail Investor Day on May 20, 2025 in Redmond, WA. Shareholders can interact with executive team and view product demos Executive Team MicroVision Retail Investor Day Redmond Product Demos
PRESS RELEASE published on 04/08/2025 at 22:30, 1 year 1 month ago Forte Group Announces Strategic Initiatives to Strengthen Financial Position Forte Group Holdings Inc. plans to settle debts with shares, cancels marketing agreement with Aktiencheck. Details on strategic financial decisions and future outlook disclosed Debt Settlement Financial Strategy Future Outlook Forte Group Holdings Inc. Marketing Agreement Cancellation
Published on 05/09/2026 at 01:30, 19 hours 10 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 20 hours 40 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/09/2026 at 19:05, 1 hour 35 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 1 hour ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 1 hour ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 2 days 1 hour ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 2 days 1 hour ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 2 days 2 hours ago DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 17:45, 2 days 2 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL